Promoted for
Beginners
Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.
How to buy Praxis Precision Medicines stock in Canada | $42.61
Own Praxis Precision Medicines shares in just a few minutes.
Praxis Precision Medicines, Inc is a biotechnology business based in the US. Praxis Precision Medicines shares (PRAX.US) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $42.61 – an increase of 1.55% over the previous week. Praxis Precision Medicines employs 50 staff and has a market cap (total outstanding shares value) of $1.7 billion.
How to buy shares in Praxis Precision Medicines
- Choose a platform. If you're a beginner, our share-dealing table below can help you choose.
- Open your account. You'll need your ID, bank details and national insurance number.
- Confirm your payment details. You'll need to fund your account with a bank transfer, debit card or credit card.
- Search the platform for stock code: PRAX in this case.
- Research Praxis Precision Medicines shares. The platform should provide the latest information available.
- Buy your Praxis Precision Medicines shares. It's that simple.
What's in this guide?
- Can I buy shares in Praxis Precision Medicines?
- Praxis Precision Medicines shares summary
- Compare share dealing platforms
- Is Praxis Precision Medicines stock a buy or sell?
- Praxis Precision Medicines performance over time
- Can I short Praxis Precision Medicines shares?
- Praxis Precision Medicines's financials
- Does Praxis Precision Medicines pay a dividend?
- Other common questions
Praxis Precision Medicines share price
Use our graph to track the performance of PRAX stocks over time.Praxis Precision Medicines shares at a glance
Information last updated 2020-12-02.
| Latest market close | $42.61 |
|---|---|
| 52-week range | $19 - $46.71 |
| 50-day moving average | $33.4859 |
| 200-day moving average | $33.4859 |
| Wall St. target price | $57 |
| Dividend yield | N/A (0%) |
| Earnings per share (TTM) | N/A |
Compare online trading platforms
Is it a good time to buy Praxis Precision Medicines stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Praxis Precision Medicines price performance over time
Historical closes compared with the last close of $42.61
| 1 week (2021-01-07) | -29.22% |
|---|---|
| 1 month (2020-12-16) | -2.81% |
| 3 months (2020-10-16) | 53.27% |
Praxis Precision Medicines financials
| Gross profit TTM | USD$0 |
|---|---|
| Return on assets TTM | 0% |
| Return on equity TTM | 0% |
| Profit margin | 0% |
| Book value | N/A |
| Market capitalisation | USD$1.7 billion |
TTM: trailing 12 months
How to short and sell Praxis Precision Medicines shares
- Create a CFD or spread betting account.
- Search for the stock code. E.g. "PRAX.US"
- Choose your position size.
- Select "sell" rather than "buy".
- Confirm your position and keep tabs on it. You may wish to set limits on your position.
There are currently 1.1 million Praxis Precision Medicines shares held short by investors – that's known as Praxis Precision Medicines's "short interest". This figure is 103.4% up from 543,282 last month.
There are a few different ways that this level of interest in shorting Praxis Precision Medicines shares can be evaluated.
Praxis Precision Medicines's "short interest ratio" (SIR)
Praxis Precision Medicines's "short interest ratio" (SIR) is the quantity of Praxis Precision Medicines shares currently shorted divided by the average quantity of Praxis Precision Medicines shares traded daily (recently around 476404.74137931). Praxis Precision Medicines's SIR currently stands at 2.32. In other words for every 100,000 Praxis Precision Medicines shares traded daily on the market, roughly 2320 shares are currently held short.
However Praxis Precision Medicines's short interest can also be evaluated against the total number of Praxis Precision Medicines shares, or, against the total number of tradable Praxis Precision Medicines shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Praxis Precision Medicines's short interest could be expressed as 0.03% of the outstanding shares (for every 100,000 Praxis Precision Medicines shares in existence, roughly 30 shares are currently held short) or 0.0416% of the tradable shares (for every 100,000 tradable Praxis Precision Medicines shares, roughly 42 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Praxis Precision Medicines.
Find out more about how you can short Praxis Precision Medicines stock.
Praxis Precision Medicines share dividends
We're not expecting Praxis Precision Medicines to pay a dividend over the next 12 months. However, you can browse other dividend-paying shares in our guide.
Praxis Precision Medicines overview
Praxis Precision Medicines, Inc., a clinical-stage biopharmaceutical company, develops therapies for central nervous system disorders characterized by neuronal imbalance. Its lead product candidates include PRAX-114, an extrasynaptic-preferring GABAA receptor positive allosteric modulator that is in Phase IIa clinical trial for the treatment of major depressive disorder and perimenopausal depression; and PRAX-944, a selective small molecule inhibitor of T-type calcium channels, which is in Phase IIa clinical trial for the treatment of essential tremor. The company is also developing PRAX-562, a persistent sodium current blocker that is in Phase I clinical trial to treat severe pediatric epilepsy and adult cephalgia; PRAX-222, an antisense oligonucleotide for patients with gain-of-function (GOF) SCN2A epilepsy; and KCNT1 program for the treatment of KCNT1 GOF epilepsy. It has a cooperation and license agreement with RogCon Inc.; a license agreement Purdue Neuroscience Company; and a research collaboration, option, and license agreement with Ionis Pharmaceuticals, Inc. The company was incorporated in 2015 and is based in Cambridge, Massachusetts.
Frequently asked questions
Disclaimer: This information should not be interpreted as an endorsement of futures, stocks, ETFs, CFDs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore are not appropriate for all investors. Trading CFDs and forex on leverage comes with a higher risk of losing money rapidly. Past performance is not an indication of future results. Consider your own circumstances, and obtain your own advice, before making any trades.
More guides on Finder
-
How to buy resTORbio stock in Canada
Steps to owning and managing TORC, with 24-hour and historical pricing before you buy.
-
How to buy Top Glove Corporation Bhd stock in Canada | $8.73
Steps to owning and managing TGLVY, with 24-hour and historical pricing before you buy.
-
How to buy Briggs-and-Stratton Corporation stock in Canada
Steps to owning and managing BGG, with 24-hour and historical pricing before you buy.
-
How to buy Riot Blockchain stock in Canada | $4.1
Steps to owning and managing RIOT, with 24-hour and historical pricing before you buy.
-
How to buy XL Fleet stock in Canada | $20.74
Steps to owning and managing Opendoor stocks, with 24-hour and historical pricing before you buy.
-
How to buy Opendoor stock in Canada | $26.23
Steps to owning and managing Opendoor stocks, with 24-hour and historical pricing before you buy.
-
How to buy MGT Capital Investments stock in Canada | $0.026
Ever wondered how to buy shares in MGT Capital Investments? We explain how and compare a range of providers that can give you access to many brands, including MGT Capital Investments.
-
How to buy Switchback Energy Acquisition Corporation stock in Canada | $43
Ever wondered how to buy shares in Switchback Energy Acquisition? We explain how and compare a range of providers that can give you access to many brands, including Switchback Energy Acquisition.
-
How to buy SkyWest stock in Canada | $30.49
Ever wondered how to buy shares in SkyWest? We explain how and compare a range of providers that can give you access to many brands, including SkyWest.
-
How to buy Spectrum Brands stock in Canada | $68.93
Ever wondered how to buy shares in Spectrum Brands Holdings? We explain how and compare a range of providers that can give you access to many brands, including Spectrum Brands Holdings.